Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) England), 2017-05, Vol.19 (5), p.S15-S15
Main Authors: Tryggestad, A.A, Bigalke, I, Axcrona, K, Inderberg, E, Skorstad, G, Hønnåshagen, K, Skoge, L, Tjeldhorn, L, Mowinckel, L, Sæbø-Larse, S, Jørgensen, J.L, Andreassen, G.S, Josefsen, D, Axcrona, U, Aamdal, S, Lilleby, W, Brennhovd, B, Dueland, S, Kvalheim, G
Format: Article
Language:English
Subjects:
Advanced Basic Science
Other
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1465-3249
DOI:10.1016/j.jcyt.2017.02.025